274 related articles for article (PubMed ID: 15827798)
1. Intraoperative subareolar injection of 99mTc-labeled sulfur colloid results in consistent sentinel lymph node identification.
Zogakis TG; Wetherille RE; Christensen RD; Ose KJ; Friedman JD; Colbert M; Svendsen CA; Sanan OK; Tuttle TM
Ann Surg Oncol; 2005 Feb; 12(2):167-72. PubMed ID: 15827798
[TBL] [Abstract][Full Text] [Related]
2. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
[TBL] [Abstract][Full Text] [Related]
3. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.
Chagpar A; Martin RC; Chao C; Wong SL; Edwards MJ; Tuttle T; McMasters KM
Arch Surg; 2004 Jun; 139(6):614-8; discussion 618-20. PubMed ID: 15197087
[TBL] [Abstract][Full Text] [Related]
4. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.
Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM
J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139
[TBL] [Abstract][Full Text] [Related]
5. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
Kern KA
J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
[TBL] [Abstract][Full Text] [Related]
6. Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer.
Povoski SP; Olsen JO; Young DC; Clarke J; Burak WE; Walker MJ; Carson WE; Yee LD; Agnese DM; Pozderac RV; Hall NC; Farrar WB
Ann Surg Oncol; 2006 Nov; 13(11):1412-21. PubMed ID: 16957969
[TBL] [Abstract][Full Text] [Related]
7. Sequential dermal-peritumoral radiocolloid injection for sentinel node biopsy for breast cancer: the University of Florida experience.
Feezor RJ; Kasraeian A; Copeland EM; Schell SR; Hochwald SN; Cendan J; Drane W; Mastin S; Wilkinson E; Lind DS
Am Surg; 2002 Aug; 68(8):684-7; discussion 687-8. PubMed ID: 12206602
[TBL] [Abstract][Full Text] [Related]
8. [Validation of sentinel node in breast cancer].
Vergara-Fernández O; Cortés-González R; Medina-Franco H
Rev Invest Clin; 2004; 56(3):309-13. PubMed ID: 15612512
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma.
Shimazu K; Tamaki Y; Taguchi T; Akazawa K; Inoue T; Noguchi S
Cancer; 2004 Jun; 100(12):2555-61. PubMed ID: 15197796
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence.
Murawa D; Hirche C; Dresel S; Hünerbein M
Br J Surg; 2009 Nov; 96(11):1289-94. PubMed ID: 19847873
[TBL] [Abstract][Full Text] [Related]
11. Comparison of intradermal and subcutaneous injections in lymphatic mapping.
Kersey TW; Van Eyk J; Lannin DR; Chua AN; Tafra L
J Surg Res; 2001 Apr; 96(2):255-9. PubMed ID: 11266281
[TBL] [Abstract][Full Text] [Related]
12. A validation trial of subdermal injection compared with intraparenchymal injection for sentinel lymph node biopsy in breast cancer.
Vargas HI; Tolmos J; Agbunag RV; Mishkin F; Vargas MP; Diggles L; Gonzalez KD; Venegas R; Klein SR; Khalkhali I
Am Surg; 2002 Jan; 68(1):87-91. PubMed ID: 12467326
[TBL] [Abstract][Full Text] [Related]
13. Subareolar injection of 99mTc facilitates sentinel lymph node identification.
Tuttle TM; Colbert M; Christensen R; Ose KJ; Jones T; Wetherille R; Friedman J; Swenson K; McMasters KM
Ann Surg Oncol; 2002; 9(1):77-81. PubMed ID: 11829434
[TBL] [Abstract][Full Text] [Related]
14. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
[TBL] [Abstract][Full Text] [Related]
15. Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy.
Noguchi M; Inokuchi M; Zen Y
J Surg Oncol; 2009 Aug; 100(2):100-5. PubMed ID: 19479943
[TBL] [Abstract][Full Text] [Related]
16. Subareolar versus peritumoral injection for location of the sentinel lymph node.
Klimberg VS; Rubio IT; Henry R; Cowan C; Colvert M; Korourian S
Ann Surg; 1999 Jun; 229(6):860-4; discussion 864-5. PubMed ID: 10363900
[TBL] [Abstract][Full Text] [Related]
17. Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer.
Bauer TW; Spitz FR; Callans LS; Alavi A; Mick R; Weinstein SP; Bedrosian I; Fraker DL; Bauer TL; Czerniecki BJ
Ann Surg Oncol; 2002 Mar; 9(2):169-76. PubMed ID: 11888875
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node pressure in breast cancer.
Nathanson SD; Mahan M
Ann Surg Oncol; 2011 Dec; 18(13):3791-6. PubMed ID: 21626079
[TBL] [Abstract][Full Text] [Related]
19. Are 3 sentinel nodes sufficient?
Chagpar AB; Scoggins CR; Martin RC; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; McMasters KM;
Arch Surg; 2007 May; 142(5):456-9; discussion 459-60. PubMed ID: 17515487
[TBL] [Abstract][Full Text] [Related]
20. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.
Rodier JF; Velten M; Wilt M; Martel P; Ferron G; Vaini-Elies V; Mignotte H; Brémond A; Classe JM; Dravet F; Routiot T; de Lara CT; Avril A; Lorimier G; Fondrinier E; Houvenaeghel G; Avigdor S
J Clin Oncol; 2007 Aug; 25(24):3664-9. PubMed ID: 17485709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
